Evaluation of immune response following one dose of an AS03A-adjuvanted H1N1 2009 pandemic influenza vaccine in Japanese adults 65 years of age or older

• Principais autores: Hideyuki Ikematsu (Autor), Kazuyoshi Tenjinbaru (Autor), Ping Li (Autor), Anuradha Madan (Autor), David Vaughn (Autor)
• Formato: Livro
• Publicado em: Taylor & Francis Group, 2012-08-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Objective: This study assessed the immunogenicity, long-term persistence of immune response and safety of a single dose of an A/California/07/2009 H1N1 pandemic influenza vaccine adjuvanted with AS03 (α-tocopherol and squalene based oil-in-water emulsion Adjuvant System) in subjects ≥ 65 y of age (N...